1. Home
  2. MURA vs TAIT Comparison

MURA vs TAIT Comparison

Compare MURA & TAIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MURA
  • TAIT
  • Stock Information
  • Founded
  • MURA 2013
  • TAIT 1989
  • Country
  • MURA Ireland
  • TAIT United States
  • Employees
  • MURA N/A
  • TAIT N/A
  • Industry
  • MURA
  • TAIT Electronic Components
  • Sector
  • MURA
  • TAIT Technology
  • Exchange
  • MURA Nasdaq
  • TAIT Nasdaq
  • Market Cap
  • MURA 45.8M
  • TAIT 13.3M
  • IPO Year
  • MURA N/A
  • TAIT 1995
  • Fundamental
  • Price
  • MURA $2.62
  • TAIT $2.21
  • Analyst Decision
  • MURA Strong Buy
  • TAIT
  • Analyst Count
  • MURA 4
  • TAIT 0
  • Target Price
  • MURA $13.00
  • TAIT N/A
  • AVG Volume (30 Days)
  • MURA 206.7K
  • TAIT 11.6K
  • Earning Date
  • MURA 05-14-2025
  • TAIT 05-15-2025
  • Dividend Yield
  • MURA N/A
  • TAIT 9.05%
  • EPS Growth
  • MURA N/A
  • TAIT N/A
  • EPS
  • MURA N/A
  • TAIT 0.01
  • Revenue
  • MURA N/A
  • TAIT $4,260,000.00
  • Revenue This Year
  • MURA $34.35
  • TAIT N/A
  • Revenue Next Year
  • MURA N/A
  • TAIT N/A
  • P/E Ratio
  • MURA N/A
  • TAIT $228.90
  • Revenue Growth
  • MURA N/A
  • TAIT N/A
  • 52 Week Low
  • MURA $0.95
  • TAIT $2.01
  • 52 Week High
  • MURA $4.74
  • TAIT $3.05
  • Technical
  • Relative Strength Index (RSI)
  • MURA 50.82
  • TAIT 47.91
  • Support Level
  • MURA $2.59
  • TAIT $2.15
  • Resistance Level
  • MURA $2.72
  • TAIT $2.28
  • Average True Range (ATR)
  • MURA 0.15
  • TAIT 0.08
  • MACD
  • MURA -0.02
  • TAIT 0.01
  • Stochastic Oscillator
  • MURA 29.41
  • TAIT 26.48

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

About TAIT Taitron Components Incorporated

Taitron Components Inc is a supplier of originally designed and manufactured (ODM) products that include value-added engineering and turn-key solutions. It focuses on providing original equipment manufacturers (OEMs) and contracts electronic manufacturers (CEMs) with ODM products for their multi-year turn-key projects and ODM electronic components. The company's product offerings range from discrete semiconductors to small electronic devices. The company also distributes brand-name electronic components with a vast inventory available on hand. Its Taiwan and China locations, provide support for inventory sourcing, purchases, and coordinating the manufacture of ODM Projects and ODM Components.

Share on Social Networks: